Cargando…
Ramulus mori (Sangzhi) alkaloids regulates gut microbiota disorder and its metabolism profiles in obese mice induced by a high-fat diet
The imbalance of gut microbiota has been confirmed to have a close pathological and physiological correlation with obesity and metabolic syndrome. Ramulus Mori (Sangzhi) Alkaloids (SZ-A) derived from twigs of mulberry was approved by the National Medical Products Administration of China in 2020 for...
Autores principales: | Liu, Dongdong, Ye, Jun, Yan, Yu, Chen, Yanmin, Wang, Hongliang, Wang, Mo, Feng, Yu, Li, Renjie, Xu, Xiaoyan, Jiang, Yu, Lian, Chunfang, Yang, Yanfang, Meng, Yingying, Liu, Yuling, Jiang, Weizhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102453/ https://www.ncbi.nlm.nih.gov/pubmed/37063280 http://dx.doi.org/10.3389/fphar.2023.1166635 |
Ejemplares similares
-
Pharmacokinetics and tissue distribution of Ramulus Mori (Sangzhi) alkaloids in rats and its effects on liver enzyme activity
por: Liu, Zhihua, et al.
Publicado: (2023) -
Ramulus Mori (Sangzhi) Alkaloids Ameliorate Obesity-Linked Adipose Tissue Metabolism and Inflammation in Mice
por: Sun, Qian-Wen, et al.
Publicado: (2022) -
Ramulus Mori (Sangzhi) Alkaloids Alleviate High-Fat Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice
por: Chen, Yan-Min, et al.
Publicado: (2022) -
Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice
por: Liu, Quan, et al.
Publicado: (2021) -
Integration of Transcriptomics and Lipidomics Profiling to Reveal the Therapeutic Mechanism Underlying Ramulus mori (Sangzhi) Alkaloids for the Treatment of Liver Lipid Metabolic Disturbance in High-Fat-Diet/Streptozotocin-Induced Diabetic Mice
por: Wang, Fan, et al.
Publicado: (2023)